Harrow (HROW) Deferred Taxes (2017 - 2024)

Harrow (HROW) recorded quarterly Deferred Taxes of $20000.0 in Q3 2024, up 106.94% quarter-over-quarter from -$288000.0 in Q1 2023.

Harrow (HROW) Deferred Taxes (2017 - 2024) Analysis & Trends

Harrow's Deferred Taxes history runs 3 years deep, the most recent figure standing at $20000.0 for Q3 2024.

In Q3 2024, Deferred Taxes changed N/A year-over-year to $20000.0; the TTM figure through Sep 2024 stood at -$1.1 million (changed N/A YoY), while the FY2018 annual figure was $3.3 million, up 452.3% from the prior year.
Deferred Taxes was $20000.0 for Q3 2024 at Harrow, up from -$288000.0 in the prior quarter.
In the past five years, Deferred Taxes ranged from a high of $20000.0 in Q3 2024 to a low of -$288000.0 in Q1 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Deferred Taxes (Qtr)
1	Teva Pharmaceutical Industries	38.34 Bn	34.60 Bn	1.97 Bn	-22.00 Mn
2	Zoetis	33.27 Bn	31.33 Bn	1.62 Bn	34.00 Mn
3	United Therapeutics	23.75 Bn	21.60 Bn	648.10 Mn	25.90 Mn
4	Aurora Cannabis	17.11 Bn	17.03 Bn	33.43 Mn	14,341.73
5	Neurocrine Biosciences	16.37 Bn	15.05 Bn	800.70 Mn	-61.10 Mn
6	Elanco Animal Health	11.78 Bn	11.35 Bn	785.00 Mn	-
7	Alkermes	7.05 Bn	6.54 Bn	-116.06 Mn	-8.79 Mn
8	Lantheus Holdings	6.49 Bn	5.99 Bn	230.92 Mn	19.33 Mn
9	Hims & Hers Health	6.19 Bn	5.44 Bn	396.79 Mn	-13.98 Mn
10	Harrow	1.23 Bn	1.14 Bn	27.05 Mn	-

Download Data